TOP NEWS

Mirium Pharmaceuticals Finds $120M

San Diego-based Mirium Pharmaceuticals, which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The funding was led by New Enterprise Associates (NEA), and also included Deerfield Management, Frazier Healthcare Partners, Novo Holdings A/S, Pappas Capital, RiverVest

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.